References
- 1. Cernea S. Heart failure and chronic kidney disease in type 2 diabetes. Journal of Interdisciplinary Medicine. 2016;1:252-258.
- 2. Battiprolu PK, Gillette TG, Wang ZV, et al. Diabetic Cardiomyopathy: Mechanisms and Therapeutic Targets. Drug Discov Today Dis Mech. 2010;7:e135-e143.10.1016/j.ddmec.2010.08.001
- 3. McMurray JJ, Gerstein HC, Holman RR, et al. Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored. Lancet Diabetes Endocrinol. 2014;2:843-851.10.1016/S2213-8587(14)70031-2
- 4. Matloch Z, Kotulák T, Haluzík M. The role of epicardial adipose tissue in heart disease. Physiol Res. 2016;65:23-32.
- 5. Wang CP, Hsu HL, Hung WC, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf). 2009;70:876-882.10.1111/j.1365-2265.2008.03411.x
- 6. Iacobellis G, Barbaro G, Gerstein HC. Relationship of epicardial fat thickness and fasting glucose. Int J Cardiol. 2008;128:424-426.
- 7. Nakanishi K, Fukuda S, Tanaka A, et al. Epicardial Adipose Tissue Accumulation Is Associated With Renal Dysfunction and Coronary Plaque Morphology on Multidetector Computed Tomography. Circ J. 2016;80:196-201.10.1253/circj.CJ-15-0477
- 8. Doesch C, Haghi D, Flüchter S, et al. Epicardial adipose tissue in patients with heart failure. J Cardiovasc Magn Reson. 2010;12:40.
- 9. American Diabetes Association. Standards of Medical Care in Diabetes-2017. Diabetes Care. 2017;40(Suppl 1):S1-S135.
- 10. Laborator Synevo. Referintele specifice tehnologiei de lucru utilizate. Available at: https://www.synevo.ro/hemoglobina-glicata-hb-a1c/
- 11. Laborator Synevo. Referintele specifice tehnologiei de lucru utilizate. Available at: https://www.synevo.ro/colesterol-ldl/
- 12. Laborator Synevo. Referintele specifice tehnologiei de lucru utilizate. Available at: https://www.synevo.ro/creatinina-serica/
- 13. Levey AS, Stevens LA, Schmid CH, et al. CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration). A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150:604-612.
- 14. Durnin J, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr. 1974;32:77–97.
- 15. Nagueh SF, Smiseth OA, Appleton CP, et al. ASE/EACVI GUIDELINES AND STANDARDS. Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2016;17:1321-1360.
- 16. Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE). Eur Heart J Cardiovasc Imaging. 2015;16:577-605.
- 17. Boonman-de Winter LJ, Rutten FH, Cramer MJ, et al. High prevalence of previously unknown heart failure and left ventricular dysfunction in patients with type 2 diabetes. Diabetologia. 2012;55:2154-2162.10.1007/s00125-012-2579-0
- 18. Henry RM, Paulus WJ, Kamp O, et al. Deteriorating glucose tolerance status is associated with left ventricular dysfunction--the Hoorn Study. Neth J Med. 2008;66:110-117.
- 19. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation. 2007;115:3213–3223.
- 20. Ojji DB, Adebiyi AA, Oladapo OO, et al. Left ventricular geometric patterns in normotensive type 2 diabetic patients in Nigeria: an echocardiographic study. Prev Cardiol. 2009;12:184-188.
- 21. De Jong KA, Czeczor JK, Sithara S, et al. Obesity and type 2 diabetes have additive effects on left ventricular remodelling in normotensive patients-a cross sectional study. Cardiovasc Diabetol. 2017;16:21.
- 22. Masugata H, Senda S, Goda F, et al. Echocardiographic assessment of the cardio-renal connection: is left ventricular hypertrophy or diastolic function more closely correlated with estimated glomerular filtration rate in patients with cardiovascular risk factors? Clin Exp Hypertens. 2010;32:113-120.10.3109/10641960902993145
- 23. Salazar J, Luzardo E, Mejías JC, et al. Epicardial Fat: Physiological, Pathological, and Therapeutic Implications. Cardiol Res Pract. 2016;2016:1291537.
- 24. Parisi V, Rengo G, Pagano G, et al. Epicardial adipose tissue has an increased thickness and is a source of inflammatory mediators in patients with calcific aortic stenosis. Int J Cardiol. 2015;186:167-169.
- 25. Noyes AM, Dua K, Devadoss R, et al. Cardiac adipose tissue and its relationship to diabetes mellitus and cardiovascular disease. World J Diabetes. 2014;5:868-876.10.4239/wjd.v5.i6.868
- 26. Nasrallah MP, Ziyadeh FN. Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney. Semin Nephrol. 2013;33:54-65.
- 27. Ortega Moreno L, Lamacchia O, Copetti M, et al. Serum Adiponectin and Glomerular Filtration Rate in Patients with Type 2 Diabetes. PLoS One. 2015;10:e0140631.
- 28. Puurunen VP, Lepojärvi ES, Piira OP, et al. High plasma leptin levels are associated with impaired diastolic function in patients with coronary artery disease. Peptides. 2016;84:17-21.10.1016/j.peptides.2016.08.002
- 29. Dey D, Nakazato R, Li D, et al. Epicardial and thoracic fat - Noninvasive measurement and clinical implications. Cardiovasc Diagn Ther. 2012;2:85-93.
- 30. Rabkin SW, Campbell H. Comparison of reducing epicardial fat by exercise, diet or bariatric surgery weight loss strategies: a systematic review and meta-analysis. Obes Rev. 2015;16:406-415.
- 31. Benedek T, Oprincariu D, Rat N, et al. The Assessment of Epicardial Adipose Tissue in Acute Coronary Syndrome Patients. A Systematic Review. Journal of Cardiovascular Emergencies. 2017;3:18-29.
- 32. Cardoso AF, Furtado MS, Grindler J, et al. Epicardial Fat Thickness Correlates with P-wave Duration, Left Atrial Size and Decreased Left Ventricular Systolic Function in Morbid Obesity. Nutr Metab Cardiovasc Dis. 2017;27:473-582.